FDA Clearance Tracker · DEN220030
RemeOs Screw LAG Solid
Last checked: Nov 19, 2026Latest source record: Mar 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 29, 2023
De Novo granted
Time to decision
329 days
Received May 4, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN220030
- Device name
- RemeOs Screw LAG Solid
- Applicant
- Bioretec, Ltd.
- Applicant location
- Tampere, FI
- Received
- May 4, 2022
- Decided
- Mar 29, 2023
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.3041
- Specialty
- Orthopedic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN220030
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Bioretec, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261057 · Decided Sep 4, 2026 · 157 days after receipt
Device type: Screw, Fixation, Bone (HWC) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.